Suppr超能文献

β-内啡肽嵌合肽:体内通过血脑屏障的转运及脑内二硫键的裂解

Beta-endorphin chimeric peptides: transport through the blood-brain barrier in vivo and cleavage of disulfide linkage by brain.

作者信息

Pardridge W M, Triguero D, Buciak J L

机构信息

Department of Medicine, UCLA School of Medicine 90024-1682.

出版信息

Endocrinology. 1990 Feb;126(2):977-84. doi: 10.1210/endo-126-2-977.

Abstract

Water soluble peptides are normally not transported through the brain capillary wall, i.e. the blood-brain barrier (BBB). Chimeric peptides may be transportable through the BBB and are formed by the covalent coupling of a nontransportable peptide, e.g. beta-endorphin, to a transportable peptide vector, e.g. cationized albumin, using disulfide-based coupling reagents such as N-succinimidyl 3-[2-pyridyldithio(propionate)] (SPDP). The transcytosis of peptide into brain parenchyma, as opposed to vascular sequestration of blood-borne peptide, was quantified using an internal carotid artery perfusion/capillary depletion method. It is shown that [125I]beta-endorphin is not transported through the BBB, but is rapidly cleaved to free [125I] tyrosine via capillary peptidase. Therefore, chimeric peptide was prepared using [125I] [D-Ala2]beta-endorphin (DABE), owing to the resistance of this analogue to peptidase degradation. The [125I] DABE-cationized albumin chimeric peptide is shown to enter brain parenchyma at a rate comparable to that reported previously for unconjugated cationized albumin. When the [125I] DABE-cationized albumin chimeric peptide was incubated with rat brain homogenate at 37 C, the free [125I] DABE was liberated from the cationized albumin conjugate prior to its subsequent degradation into free [125I] tyrosine. Approximately 50% of the chimeric peptide was cleaved within 60 sec of incubation at 37 C. These studies demonstrate that 1) [125I]beta-endorphin is not transported through the BBB in its unconjugated form, 2) a [125I] DABE-cationized albumin chimeric peptide is transported through the BBB into brain parenchyma at a rate comparable to the unconjugated cationized albumin, and 3) brain contains the necessary disulfide reductases for rapid cleavage of the chimeric peptide into free beta-endorphin and this cleavage occurs before degradation of the [125I] DABE into [125I] tyrosine.

摘要

水溶性肽通常不能穿过脑毛细血管壁,即血脑屏障(BBB)。嵌合肽可能能够穿过血脑屏障,它是通过使用基于二硫键的偶联试剂(如N-琥珀酰亚胺基3-[2-吡啶基二硫代(丙酸)](SPDP))将不可转运的肽(如β-内啡肽)与可转运的肽载体(如阳离子化白蛋白)共价偶联而形成的。与血源性肽在血管中的滞留相反,肽向脑实质的转胞吞作用是使用颈内动脉灌注/毛细血管清除法进行定量的。结果表明,[125I]β-内啡肽不能穿过血脑屏障,而是通过毛细血管肽酶迅速裂解为游离的[125I]酪氨酸。因此,由于该类似物对肽酶降解具有抗性,使用[125I][D-Ala2]β-内啡肽(DABE)制备了嵌合肽。[125I]DABE-阳离子化白蛋白嵌合肽进入脑实质的速率与先前报道的未缀合阳离子化白蛋白的速率相当。当[125I]DABE-阳离子化白蛋白嵌合肽在37℃下与大鼠脑匀浆孵育时,游离的[125I]DABE在随后降解为游离的[125I]酪氨酸之前从阳离子化白蛋白缀合物中释放出来。在37℃孵育60秒内,约50%的嵌合肽被裂解。这些研究表明:1)[125I]β-内啡肽以未缀合的形式不能穿过血脑屏障;2)[125I]DABE-阳离子化白蛋白嵌合肽穿过血脑屏障进入脑实质的速率与未缀合的阳离子化白蛋白相当;3)脑内含有将嵌合肽迅速裂解为游离β-内啡肽所需的二硫键还原酶,且这种裂解发生在[125I]DABE降解为[125I]酪氨酸之前。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验